Optum’s Home-Based Care Arm Propelling Growth at UnitedHealth Group

UnitedHealth Group’s (NYSE: UNH) subsidiary OptumHealth is a growth engine for the massive health care and insurance company. In addition to other services OptumHealth holds a substantial home health and hospice business. Optum is in the process of acquiring the home health and hospice provider Amedisys (NASDAQ: AMED), with closing expected before the end of […]

Amedisys Hospice Segment Increased Revenue, Census in Q2

Amedisys Inc. (NASDAQ: AMED) saw hospice revenue and census growth as it awaits the final determination of its pending acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. The company’s hospice segment earned $204 million during Q2 2024, up from $199.2 million year over year. Amedisys also saw a 0.4% increase in same-store average daily census […]

Optum Fuels Growth for UnitedHealth Group with Amedisys Deal in the Wings

UnitedHealth Group’s (NYSE: UNH) subsidiary Optum, which holds a substantial home health and hospice business, continues to be a major driver of the company’s growth. Optum is in the process of acquiring the home health and hospice provider Amedisys (NASDAQ: AMED), with closing expected before the end of the year, pending some regulatory hurdles. Optum […]

Amedisys Expects to Close UnitedHealth Group Deal By Q4

The recent divestment of home health locations by Amedisys (NASDAQ: AMED) likely will give the company a smoother course towards closing its acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Last week, Amedisys announced the sale of the locations to the home health and hospice provider VitalCaring for an undisclosed amount, according to a […]

Amedisys Divests Locations in Advance of Optum Deal

Amedisys (NASDAQ: AMED) has divested a number of home health locations in a sale to VitalCaring. VitalCaring also acquired some Unitedhealth Group (NYSE: UNH) care centers in the deal. Financial terms were undisclosed. Rumors of a potential divestiture began circulating in May. “On June 28, 2024, [Amedisys], UnitedHealth Group Incorporated and certain of their respective […]

Amedisys Reports Hospice Revenue Growth

Amedisys Inc. (NASDAQ: AMED) has seen gains in its hospice segment as it waits for closure on its pending acquisition by Optum. The company’s hospice segment brought in $201 million in the first quarter of the year, up from $193.4 million year over year. Cost per day rose 2.3% during the quarter, however, largely due […]

UnitedHealth Group Set for Further Acquisitions

Despite intensifying regulatory scrutiny on its deals, UnitedHealth Group (NYSE: UNH) remains poised for further acquisitions. During the past two years, the insurance giant has completed a slew of acquisitions spanning much of the health care continuum — including hospice, palliative care and home health — as well as health care technology, largely through its […]

Executive Moves at UnitedHealth Group, Treasure Coast Hospice

UnitedHealth Group’s President, COO Change UnitedHealth Group (NYSE: UNH) has announced the retirement of President and COO Dirk McMahon. The company has not yet named his predecessor. McMahon will step down on April 1 after more than two decades with the insurance giant reported in a recent Securities and Exchange Commission (SEC) filing. He most […]

DOJ Considers Lawsuit to Block Amedisys-Optum Transaction

The U.S. Department of Justice (DOJ) is reportedly mulling a possible lawsuit to block the acquisition of Amedisys (NASDAQ: AMED) by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Amedisys stock dipped 0.6% following reports of a lawsuit under consideration, SeekingAlpha reported. Optum, a subsidiary of UnitedHealth Group (NYSE: UHN), in June 2023 penned its agreement […]

Justice Department Launches UnitedHealth Group Antitrust Investigation

In case you missed it, Hospice News has launched a new specialty publication for palliative care professionals. You can subscribe to Palliative Care News here: Subscribe today! The U.S. Justice Department is investigating UnitedHealth Group (NYSE: UNH) due to antitrust concerns. During the past two years, the insurance giant has completed a slew of acquisitions […]